Chargement en cours...
PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of PCSK9 inhibitors in the primary prevention of IHD in people with HeFH.
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491336/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012917 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|